VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples
Open Access
- 1 January 2006
- journal article
- research article
- Published by Springer Nature in BMC Immunology
- Vol. 7 (1) , 11
Abstract
For immune monitoring studies during HIV vaccine clinical trials, whole blood specimens from HIV seropositive (HIV+) patients may be collected at multiple sites and sent to a central location for peripheral blood mononuclear cell (PBMC) isolation, cryopreservation and functional evaluation. In this study we show a comparison of two PBMC preparation options, Ficoll density gradient separation (Ficoll) and Cell Preparation Tubes (CPT) using shipped whole blood specimens from 19 HIV+ patients (CD4 > 350, viral load < 50). The pre- and post- cryopreservation performance of samples collected by these two methods were compared by assessment of antigen-specific IFNγ expression in CD8+ and CD8- T cells, cellular viability, and cellular recovery. The results indicate that cryopreserved PBMC samples tested for CMV- and HIV- specific interferon-gamma (IFNγ) expression performed equivalent to the respective fresh PBMC processed under both collection conditions. Compared to fresh PBMC, the viability was significantly lower for cryopreserved PBMC derived using Ficoll, although it was never less than 90%. There were no significant differences in the IFNγ response, viability, or recovery between cryopreserved PBMC derived by Ficoll and by CPT. These data suggest that CPT is an efficient system for the collection and cryopreservation of functionally active HIV+ PBMC, as well as a viable alternative to Ficoll gradient separation.Keywords
This publication has 16 references indexed in Scilit:
- Maximizing the retention of antigen specific lymphocyte function after cryopreservationJournal of Immunological Methods, 2006
- Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOTBMC Immunology, 2005
- Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowNature Medicine, 2004
- CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assaysJournal of Immunological Methods, 2003
- Effects of cryopreservation on lymphocyte immunophenotype and functionJournal of Immunological Methods, 2003
- Effect of Cryopreservation on Measurement of Cytomegalovirus-Specific Cellular Immune Responses in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Shipment Impairs Lymphocyte Proliferative Responses to Microbial AntigensClinical and Diagnostic Laboratory Immunology, 2000
- Viability and Functional Activity of Cryopreserved Mononuclear CellsClinical and Diagnostic Laboratory Immunology, 2000
- Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical TrialsClinical and Diagnostic Laboratory Immunology, 2000
- Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.Journal of Clinical Investigation, 1997